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1 Antithrombin substitution before extracorporeal circulation attenuates perioperative coagulation
activation and might decrease postoperative troponin elevation: a report of preliminary data
R Busley1, W Dietrich1, S Braun2, J Weipert3, JA Richter1
Departments of 1Anesthesiology, 2Laboratory Medicine and 3Cardiac Surgery, German Heart Center Munich, Germany 
(e-mail: r.busley@lrz.tum.de)
Critical Care 2003, 7 (Suppl 1):1 (DOI 10.1186/cc2147)
Objectives Antithrombin (AT) has been proven to have major impact
on perioperative activation of the coagulation system. The aim of this
prospective, controlled, single-blind clinical trial was to determine the
impact of AT substitution on perioperative thrombin formation.
Methods Forty male coronary artery bypass graft patients partici-
pated in the trial. Prior to skin incision, 30 patients received AT
according to a formula targeted at 120% AT activity before extracor-
poreal circulation (ECC), plus an additional 1000 U (group A, n= 10),
2000 U (group B, n= 10) or 3000 U (group C, n= 10) of AT in order
to compensate for increased consumption during ECC. Control
patients did not receive any AT substitution (group D, n= 10). The fol-
lowing parameters were determined perioperatively and until the fifth
postoperative day: AT levels, parameters of coagulation activation
(prothrombin fragment F1.2, thrombin–antithrombin complex, D-dimer),
inflammation (IL-6) and myocardial perfusion (troponin). Statistical
comparison between groups was performed using analysis of vari-
ance, followed by Fisher’s PLSD (P< 0.05) after ECC.
Results AT substitution resulted in a significant increase in AT
during ECC and until the first postoperative day (POD1), followed
by a steep decrease at days 2–5. AT substitution attenuated
thrombin generation significantly, as indicated by decreased con-
centrations of prothrombin fragments F1.2, thrombin–antithrombin
complexes and D-dimer at the end of surgery. Troponin was signifi-
cantly higher during the postoperative period in patients who did
not receive AT substitution (Fig. 1).
Conclusions A substantial decrease in AT must be taken into
account not only during ECC but also in the early postoperative
period, indicating major enhancement of coagulation activation.
High-dose AT substitution attenuates coagulation activation signifi-
cantly. Attenuation of hemostatic activation may reduce postopera-
tive complications, as lower postoperative troponin levels may
indicate in AT substituted patients.
Figure 1





























2 Phosphorycholine or heparin coating for pediatric extracorporeal circulation causes similar
biological effects in neonates and infants
A Böning1, J Scheewe1, C Friedrich1, U Bläse1, J Stieh2, P Dütschke3, JT Cremer1
Departments of 1Cardiovascular Surgery, 2Pediatric Cardiology and 3Anaesthesiology, University Hospital Kiel, Germany 
(e-mail: aboening@kielheart.uni-kiel.de)
Critical Care 2003, 7 (Suppl 1):2 (DOI 10.1186/cc2148)
Objectives Cardiac surgery for complex congenital malformations
with use of extracorporeal circulation (ECC) predisposes the patient
to an excessive systemic inflammatory response and a consecutive
capillary leak syndrome. In a prospective, randomized study, theS2
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influence of two oxygenators especially designed for pediatric use
on inflammatory markers and clinical outcome was investigated.
Methods: Forty neonates and infants (body surface area <0.36 m2)
undergoing cardiac surgery using ECC were randomised into
three groups: in the first group (n = 14) the Medtronic Minimax®
Oxygenator was used, and in the second group (n = 12) the
Dideco Liliput 1® Oxygenator was used, both with 750 ml priming
volume. In the third group the Dideco Liliput 1® Oxygenator was
filled with a reduced priming volume of 450 ml.
Parameters of interest for evaluation of a systemic inflammatory
response after ECC were IL-6, tumor necrosis factor (TNF)-α, neu-
trophil elastase, complement C3 and free hemoglobin (Hb). In
addition, erythrocyte, leukocyte and thrombocyte counts, hemoglo-
bin and C-reactive protein (CRP) values were determined at differ-
ent measurement points before, during and after surgery.
Results In all three groups, peak values for TNF-α were observed
during surgery, whereas IL-6, elastase and free Hb peaked in the
first 4 hours. Highest values for leucocytes and CRP were
obtained between 24 and 72 hours after surgery. Erythrocyte and
thrombocyte counts as well as Hb values were lowest at ECC
onset, normalizing under substitution in the first 4 hours after
surgery. Using the Liliput/750, higher IL-6 values 1 hour and
4 hours after surgery, and higher TNF-α values during and 1 hour
after surgery could be observed, as compared with Minimax and
Liliput/450. In spite of our randomization protocol, patients in the
Liliput/750 group were significantly smaller and younger than
those in the Minimax group. Accordingly, the number of children
with a clinically complicated course (capillary leak, and longer dura-
tion of catecholamine therapy and ventilation) was higher in the
Liliput/750 group.
Conclusions Using an adequate priming volume, the systemic
inflammatory response is similar after employment of the Dideco
Liliput 1® Oxygenator and the Medtronic Minimax® Oxygenator.
Tip-to-tip surface coating of the ECC with either heparin or phos-
phorylcholine appears to have similar biological effects in neonates
and infants undergoing cardiac surgery.
3 Role of parathyroid-hormone-related peptide in volume or pressure loaded pulmonary vasculature
R Zimmermann1, J Kreuder1, J Sokolova2, I Michel-Behnke1, D Schranz1, KD Schlüter2
Departments of 1Paediatric Cardiology and 2Physiology, University of Giessen, Germany
Critical Care 2003, 7 (Suppl 1):3 (DOI 10.1186/cc2149)
Objectives Parathyroid-hormone-related peptide (PTHrP) is a
paracrine factor expressed throughout the body with vasodilatative
qualities. In vitro, PTHrP is released from the endothelium via a
mechano-sensitive mechanism. In vivo data on changes in PTHrP
release were collected in two pediatric patient groups.
Methods (A) Twenty patients (median age 6.1 years), pre- and
postinterventional closure of an atrial septal defect (ASD), preclo-
sure Qp/Qs 2.1 ± 0.24. (B) Twenty patients (median age 8.1 years)
with pulmonary hypertension (PHT), Rp/Rs 0.36–1.79. (A) Blood
samples from pulmonary artery (PA), left atrium (LA), systemic artery
(SA) and superior vena cava (SVC); and (B) from PA and SA (base-
line, after oxygen and after nebulized iloprost). Determination of
PTHrP concentrations ([PTHrP]) by quantitative immunoblot, nor-
malized to SA-[PTHrP], compared by Mann–Whitney U-test.
Assessment of average peak (blood flow) velocity (APV) in the PA
with intraluminal flow wire (FloMap, Cardiometrics).
Results PHT In all 11/20 patients with significant oxygen- or ilo-
prost-induced drop in Rp/Rs, a significant difference in baseline
[PTHrP] was found (PA +43.4 ± 6.1% [P = 0.05] compared with
SA). After pressure drop (induced by oxygen/iloprost) [PTHrP]
decreased from PA/SA-[PTHrP] of 1.49 ± 0.27 → 1.02 ± 0.17
(P = 0.02) and 1.51 ± 0.21 → 0.88 ± 0.16 (P = 0.0001), respec-
tively. In all patients with lack of inducible vascular reactivity (9/20)
no difference was seen in [PTHrP] before (–6.5 ± 2.0%) or after
drug application. In addition, an increase in APV after infusion of
the endothelium-dependent vasodilator acetylcholine was only
seen in patients with significant pressure-induced PTHrP release.
Results ASD Preclosure [PTHrP] was 55 ± 14.4% higher in the
PA than in the SA, further decreasing with distance from the PA:
+11.5% ± 5.5% in the LA and –4.1 ± 6.4% in the SVC. Postclo-
sure, the [PTHrP] decreased from +55% to +14.9 ± 4.1%.
Conclusions There is a clear in vivo correlation between volume
(ASD) and pressure (PHT) load and [PTHrP] in the PA system,
with an acute decrease in [PTHrP] following drop in volume and/or
pressure. In children with PHT, PTHrP may be useful for assessing
PA endothelial function and may play a role as a diagnostic or
prognostic marker. In patients with ASD the [PTHrP] gradient indi-
cates a release from the right heart and/or proximal PA.
4 Pulmonary perfusion reduces accumulation of neutrophils in the lung during cardiopulmonary bypass
C Schlensak1, T Doenst1, M Wunderlich1, M Kleinschmidt2, F Beyersdorf1
Departments of 1Cardiovascular Surgery and 2Pathology, University of Freiburg, Germany (e-mail: schlensa@ch11.ukl.uni-freiburg.de)
Critical Care 2003, 7 (Suppl 1):4 (DOI 10.1186/cc2150)
Objectives Exposure of blood to the foreign surface area of the
bypass circuit is known to be associated with a complex ‘whole
body inflammatory reaction’, which may contribute to the develop-
ment of multiple organ dysfunction, including postoperative lungS3
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injury. Recently, we demonstrated lung ischemia during cardiopul-
monary bypass (CPB). We therefore hypothesize that (1) lung
ischemia induces an inflammatory reaction in the lung parenchyma
and (2) that pulmonary perfusion during CPB reduces the inflam-
matory reaction of the lung.
Methods Eighteen piglets (5.0 ± 0.5 kg) underwent 120 min of nor-
mothermic, total CPB without aortic cross-clamping, followed by
60 min of postbypass perfusion. Nine of them received continuous
pulmonary perfusion with autologous, oxygenated blood during CPB
while the pulmonary artery was clamped. Six additional piglets served
as control and were ventilated after sternotomy for 180 min only.
Results With the beginning of CPB, bronchial arterial blood flow
decreased to 13% of the baseline value (42.1 ± 10.4 to
5.6 ± 1.0 ml/min), remained decreased until the end of CPB, and
returned to starting levels 60 min after CPB. The decrease in
bronchial blood flow was associated with a threefold increase in
tissue lactate content. At the end of reperfusion there was a
twofold increase in alveolar septal thickness and a significant accu-
mulation of albumin, lactate dehydrogenase, neutrophils and elas-
tase in the bronchioalveolar fluid as compared with control.
Controlled pulmonary perfusion significantly ameliorated all of the
observed changes.
Conclusions (1) CPB causes a reduction in bronchial arterial
blood flow, which is associated with injury to the lung. (2) Con-
trolled pulmonary perfusion reduces injury to the lung during CPB.
(3) The inflammatory response, as evidenced by the analysis of
bronchoalveolar lavage fluid, may be caused by ischemia.
5 Influence of stress doses of hydrocortisone on levels of cytokines and nuclear transcription factor
kappa B in patients after cardiac surgery
F Weis1, J Briegel1, AE Goetz1, D Reuter1, P Fraunberger2, A Walli2, E Kilger1
Departments of 1Anaesthesiology and 2Clinical Chemistry, Klinikum Großhadern, Ludwig Maximillian University Munich, Germany (e-mail:
Erich.Kilger@ana.med.uni-muenchen.de)
Critical Care 2003, 7 (Suppl 1):5 (DOI 10.1186/cc2151)
Objectives Severe systemic inflammation (SIRS) is a serious com-
plication in patients after cardiac surgery. Hydrocortisone has been
successfully used to treat this complication (Kilger et al., Crit Care
Med, in press), potentially by lowering levels of proinflammatory
cytokines. The purpose of this prospective, randomized, double-
blind, placebo-controlled trial was to evaluate the influence of stress
doses of hydrocortisone on levels of cytokines and nuclear factor-
κB (NF-κB) in a group of high-risk patients after cardiac surgery.
Methods  Twenty-two cardiac surgical patients were randomly
assigned to receive stress doses of hydrocortisone or placebo
from the time point of induction of anesthesia until discharge from
the intensive care unit. Levels of NF-κB, IL-6, tumor necrosis factor
(TNF)-α and IL-10 were measured preoperatively, and 4 and
24 hours after the operation. Activation of NF-κB was assayed in
nuclear extracts from monocytes.
Results Patients demographic data were similar in both groups.
Conclusions In our study, hydrocortisone reduced the postopera-
tive serum levels of IL-6 and increased the levels of IL-10. The
levels of TNF-α and NF-κB remained unaffected. Increased levels
of IL-6 may be independent of TNF-α. Further studies are needed
to clarify this point.
Placebo Hydrocortisone 
(n = 11) (n =11) P
NF-κB (1 hour; %) 66 (27/125) 75 (50/98) NS
NF-kκB (24 hours; %) 86 (61/116) 59 (34/105) NS
TNF-α (4 hours) 45 (31/66) 31 (28/40) NS
TNF-α (24 hours) 41 (17/45) 27 (16/40) NS
IL-6 (pg/ml; 4 hours) 438 (396/931) 178 (93/375) <0.01
IL-6 (pg/ml; 24 hours) 281(245/454) 139 (104/231) <0.05
IL-10 (pg/ml; 4 hours) 16 (9/42) 137 (79/215) <0.001
IL-10 (pg/ml; 24 hours) 3.5 (2/10) 3.5 (1/12) NS
6 Cardiopulmonary bypass and pulmonary surfactant: influence on composition and function?
J Thul1, B Friedrich1, R Günther2, I Reiss1, D Schranz1, L Gortner1
1Zentrum für Kinderheilkunde and 2Medizinische Klinik, JL-Universität Giessen, Germany (e-mail: josefthul@hotmail.com)
Critical Care 2003, 7 (Suppl 1):6 (DOI 10.1186/cc2152)
Objectives To characterize early pulmonary surfactant features in
children undergoing cardiovascular surgery with cardiopulmonary
bypass (CPB).
Methods Fifty children were undergoing cardiac surgery for con-
genital heart disease: 35 procedures with CPB and 15 without
(control group). Tracheal aspirates (TA) were obtained by saline
lavage before and after CPB, and 4, 8 and 24 hours after pediatric
intensive care unit admission. Total protein and phospholipid (PL)
contents were assessed in native TA, in functional active large sur-
factant aggregates (LA), and in degraded small aggregates (SA).
PL profiles, surfactant apoproteins SP-A, SP-B and SP-C (enzyme-
linked immunosorbent assay), and surface activity (bubble surfac-
tometer) were analyzed in LA only.S4
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Results Surfactant properties did not change in the control group.
In the CPB group, PL content increased in TA 24 hours after CPB.
LA concentration dropped 4 hours after CPB (P < 0.01) but recov-
ered within 24 hours. The PL:protein ratio of LA was decreased at
24 hours as compared with baseline (P < 0.01). The relative
amount of phosphatidylglycerol in LA-PL content dropped linearly
over time. The relative content of the hydrophobic SP-B and SP-C
in LA increased almost threefold as compared with baseline. There
were no significant changes in biophysical function of LA.
Conclusions CPB in children induces profound changes in the
surfactant system, involving both PL and protein components. Bio-
physical function may be maintained by compensatory increases in
SP-B and SP-C of LA.
7 Evaluation of a mathematical model for blood gases and acid-base status during extracorporeal
circulation
TM Schmidt1, E Naujokat2, J Barrho2, J Albers1, U Kiencke2, CF Vahl1
1Chirurgische Universitätsklinik Heidelberg, Abt. Herzchirurgie, Heidelberg, and 2Institut für Industrielle Informationstechnik, Universität
Karlsruhe (TH), Germany (e-mail: Tanja.Schmidt@urz.uni-heidelberg.de)
Critical Care 2003, 7 (Suppl 1):7 (DOI 10.1186/cc2153)
Objectives Blood gases and acid–base status are important para-
meters during extracorporeal circulation. They are controlled by the
perfusionist, by varying arterial pump flow, gas flow over the oxi-
genator, inspiratory oxygen fraction, and carbon dioxide content in
the inspiratory gas mix. To support the perfusionist with sugges-
tions based on a control algorithm, a reliable system description is
needed. Reliability of a complex model of human acid–base and
blood gas status under extracorporeal circulation was evaluated
using clinical documentation data.
Methods  A mathematical model for blood gas and acid–base
status under extracorporeal circulation was developed. This model
consists of a multiple compartment model for the oxygenator, and
models for arterial and venous PCO2, PO2, (including temperature-
and pH-dependent shift in oxygen-binding capacity of haemoglo-
bin), SO2, bicarbonate, base excess and pH. It was implemented in
a Matlab/Simulink environment. Input parameters were oxygenator
type, gas flow, FiO2, arterial pump flow, temperature, haemoglobin
concentration and haematocrit. As output parameters, venous and
arterial SO2, PO2, PCO2 and pH were analyzed. The model was
tested by using clinical monitoring data during extracorporeal cir-
culation of patients undergoing aorto-coronary bypass grafting as
input data, and comparing the model output with the results of
conventional blood gas analyses (Rapidlab 288®) retrospectively.
Results Estimations of arterial PO2, PCO2 and SO2 were adequate.
They followed the time course appropriately and remained within a
narrow error band (Max. dev.: PO2 <17 mmHg, PCO2 <7 mmHg,
SO2 <0.01%). Venous PO2 followed appropriately (Max. dev.:
<4 mmHg), whereas PCO2 (Max. dev.: <8 mmHg) did not repro-
duce the time course. Simulations for arterial and venous pH over-
estimated continuously and were not acceptable (Max. dev.:
arterial pH +0.14, venous pH +0.07). The best results were
achieved for estimation of SO2.
Conclusions Modelling the patients’ acid–base status and blood
gases will be important for further development of control algo-
rithms used in extracorporeal circulation. The presented model
shows good concordance with clinical data for blood gas estima-
tion, but needs to be reviewed concerning acid–base status.
Further validation and in controlled experimental setups will be
required.
8 Transpulmonary vascular gradients of nitric oxide pathway metabolites and asymmetrical dimethyl-
L-arginine in the flow - or pressure-overloaded pulmonary vasculature
J Kreuder1, R Zimmermann1, D Tsikas2, I Michel-Behnke1, D Schranz1
1Department of Paediatric Cardiology, Justus-Liebig-University, and 2Department of Clinical Pharmacology, Medical School, Hannover,
Germany
Critical Care 2003, 7 (Suppl 1):8 (DOI 10.1186/cc2154)
Objectives Alterations in pulmonary vascular nitric oxide (NO) pro-
duction have been implicated in the regulation of pulmonary vascular
tone and the development of pulmonary hypertension (PH). Asymmet-
rical dimethyl-L-arginine (ADMA), an endogenous inhibitor of NO syn-
thesis, has been suggested to counteract endothelial NO production.
Methods Transpulmonary gradients of nitrite (NO2), nitrate (NO3)
and ADMA were determined in patients with increased pulmonary
flow (Qp) before (1) and after (2) interventional closure of atrial
septal defect (ASD), and in patients with increased pulmonary vas-
cular resistance (Rp) (3). Twenty patients with ASD: median age
6.1 years (range 3.5–17.1 years), median Qp/Qs 2.1, Rp/Rs
<0.12. Twenty patients with PH: median age 8.1 years (range
1.2–13.5 years), median Rp/Rs 1.1 (range 0.36–1.79). NO2, NO3
(chromatography mass spectrometry) and ADMA (high-perfor-
mance liquid chromatography) were measured in plasma samples
from the main pulmonary artery (PA) and femoral artery (SA).
Results (1) In ASD patients, NO2 showed a significant gradient
with a median SA:PA ratio of 1.34 (P < 0.01), but this was not so
for ADMA (1.05) or NO3 (1.01). (2) After closure, SA:PA ratio of
NO2 decreased to 0.89 (P < 0.05), indicating a switch from NO2S5
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production to NO2 consumption, whereas ADMA (1.00) and NO3
(0.99) remained unchanged. (3) In PH, significant transpulmonary
gradients were observed for ADMA (1.11; P < 0.05) and NO3
(1.03), but not for NO2 (0.84). Median levels of ADMA in SA
(4.08 µmol/l) were higher than those in ASD before (3.67 µmol/l)
and after (3.55 µmol/l) closure (P < 0.05).
Conclusions Analysis of transpulmonary metabolite gradients may
provide significant insights into the vascular NO pathway in the
overloaded pulmonary circulation. Reversible augmentation of intra-
pulmonary vascular NO synthesis in ASD patients contrasts with
the inappropriate NO synthesis in patients with increased Rp, to
which intrapulmonary ADMA formation may significantly contribute.
9 Cerebral cytokine expression after cardiac surgery with cardiopulmonary bypass
Ma Qing1, M Sokalska1, B Voss2, T Richter4, J Schlegel3, J Hess1, R Lange2, M-C Seghaye1
Departments of 1Pediatric Cardiology and 2Cardiovascular Surgery, Deutsches Herzentrum München, and Departments of 3Neuropathology
and 4Pathology, Technische Universität München, Germany (e-mail: ma@dhm.mhn.de)
Critical Care 2003, 7 (Suppl 1):9 (DOI 10.1186/cc2155)
Objectives Cerebral cell damage after cardiac surgery with car-
diopulmonary bypass (CPB) could, at least in part, be due to inflam-
matory processes. Our study was intended to test the hypothesis
that proinflammatory cytokines would be upregulated in the brain
during CPB, and to identify the signaling pathways involved.
Methods: Fourteen young pigs were operated on with standard-
ized CPB in either normothermia (n = 7) or moderate hypothermia
(n = 7). Six hours after termination of CPB, forehead brain tissue
was taken for detection of gene expression and synthesis of tumor
necrosis factor (TNF)-α, IL-1β, IL-6, IL-10 and inducible nitric oxide
synthase (iNOS) by competitive reverse transcription polymerase
chain reaction and/or Western blot. Phosphorylation level of the
inhibitory protein of nuclear factor-κB (IκB-α) was also measured
by Western blot. Additional probes of hippocampus, cortex and
middle brain were taken for standard histology.
Results mRNA and protein levels of TNF-α, IL-1β and IL-6, as well
as phosphorylated IκB-α, were detected in all animals, and iNOS
in 10/14 animals. The anti-inflammatory cytokine IL-10 was not
expressed in any of the animals. Histological alterations including
mild edema and a few trapped lymphocytes were found in the dif-
ferent areas investigated. Results were not affected by temperature
management during CPB.
Conclusions In our model, cardiac surgery is related to upregula-
tion of proinflammatory cytokines and iNOS in the brain. This syn-
thesis involves the activation of the nuclear factor-κB pathway. In
contrast to our previous observations in other organs, there is no
anti-inflammatory reaction in the brain 6 hours after CPB. Proin-
flammatory cytokines could contribute toward damaging brain cells
after cardiac surgery.
10 Management of extracorporeal circulation in heart surgery through a right mini-thoracotomy
MR Hoda1, E Schmitz1, H El-Achkar1, KH Krauskopf2, H Psyk1, F Lewark1, HO Vetter1
Heart Center Wuppertal, Departments of 1Cardiothoracic Surgery and 2Anaestesiology, University of Witten-Herdecke, Wuppertal, Germany
Critical Care 2003, 7 (Suppl 1):10 (DOI 10.1186/cc2156)
Objectives Minimally invasive open heart surgery requires car-
diopulmonary bypass (CPB) to be initiated via peripheral access.
We report our initial experience with a modified femoro-femoral
CPB, with the superior vena cava being drained by a supplemen-
tary cannula inserted via the jugular vein. However, because of
smaller diameter of the cannula, a slight modification to the CPB
was necessary to improve the impeded venous return.
Methods Cannulation of the superior vena cava was performed
through the right jugular vein during maintenance of anesthesia.
After right mini-thoracotomy and exposure of the femoral site, CPB
was initiated by cannulation of the femoral artery, and the inferior
vena cava via the femoral vein using the Heartport® system. A
modified open CPB system (Jostra®) was used. In order to improve
the venous return, the venous reservoir was completed with a
device offering undertow, which was monitored by a low pressure
valve in the venous and a vacuum controller in the arterial line.
Myocardial protection was performed using Bretschneider’s solu-
tion. A minimal (7–9 cm) right thoracotomy through the fourth inter-
costal space was used in all cases as the surgical approach. All
procedures were performed video-assisted.
Results During our initial experience between April and October
2002, seven patients were operated on using this technique (five
males/two females; age 52.6 ± 9.5 years; body weight
78.7 ± 19.4 kg; body surface area 1.94 ± 0.3 m2). Five patients
were operated on for mitral valve repair/replacement and two
patients for closure of an atrial septal defect. Cannula sizes were
18–20 Fr for the femoral artery, 25 Fr for the femoral vein and
16 Fr for the superior vena cava. Considering the theoretical perfu-
sion flow of 5.5 l/min, the venous flow through both cannulae was
4.27 ± 0.5 l/min. Mean CPB and cross-clamp times were
141.7 ± 38.6 min and 87.5 ± 24.5 min, respectively. Minimum
venous saturation was 97.4 ± 1.8 %. There were no cases of hos-
pital or late postoperative mortality. No case of postoperative
adverse events occurred. All patients were extubated within
8 hours postoperatively and were discharged from the intensive
care unit by the first postoperative day.S6
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Conclusions Despite our limited initial experience, and considering
the smaller internal diameter of percutaneous cardiopulmonary
bypass cannulae as compared with the classic one, the modifications
to the CPB system we used in this study improved venous drainage
significantly, so that minimally invasive open heart procedures could
be performed under optimal CPB conditions in our center.
11 Increased apoptosis of circulating leukocytes during cardiac surgery with cardiopulmonary bypass
J Hambsch, D Lenz, P Schneider, A Tarnok
Pediatric Cardiology, Herzzentrum Leipzig, University Hospital, Leipzig, Germany
Critical Care 2003, 7 (Suppl 1):11 (DOI 10.1186/cc2157)
Objectives Surgical trauma has been reported to be associated
with an elevated apoptotic rate of circulating leukocytes. However,
the effect of cardiac surgery on leukocyte apoptosis has not yet
been investigated. Our study was therefore designed to address
this question.
Methods Flow-cytometric immunophenotype data from 70 children
(age 3–16 years) who underwent cardiac surgery with (n = 50) or
without (n = 20) cardiopulmonary bypass (CPB) were analyzed for
T-cell apoptosis, based on light scatter and surface antigen
(CD45/CD3) expression. Additionally, in vitro isolated leukocytes
from healthy volunteers were incubated with serum obtained from
cardiac surgery patients before, during and after surgery. Apopto-
sis was detected by flow cytometry after staining with annexin V
and DNA condensation by laser scanning cytometry. Serum
cytokine and troponin I levels were also determined.
Results Patients undergoing CPB had elevated lymphocyte apop-
tosis. In particular, T-cell apoptosis increased from 0.45% (base-
line) to 1.34% (4 hours postoperative; analysis of variance
P = 0.0034). No effect was found during and after surgery without
CPB. These results were in accordance with in vitro findings
demonstrating elevated apoptotic activity for lymphocytes and neu-
trophils in the serum from patients with CPB at reperfusion and up
to 3 days after surgery (P < 0.01). No such activity was found in
patients operated on without CPB. The increase in apoptosis cor-
related well with the increase in troponin I and IL-10 levels.
Conclusions At present, the agents that induce apoptosis during
CPB surgery are not well identified. However, IL-10 might be
involved in peri- and postoperative neutrophil apoptosis. Increased
apoptosis of circulating lymphocytes and neutrophils further con-
tributes to the immune suppressive response to surgery with CPB,
for example by inactivating phagocytes by uptake of apoptotic cells
(e.g. via CD36) or removal of activated cells. Elevated apoptotic
activity in the blood of patients during CPB might also contribute
to the destruction of cardiomyocytes during and after pediatric
cardiac surgery.
12 In vitro bleeding time (PFA-100TM) helps to identify patients with platelet dysfuction-dependent
increased bleeding after coronary artery bypass grafting
F Zaccaria, W Dietrich, JA Richter
Department of Anesthesiology, German Heart Center Munich, Germany
Critical Care 2003, 7 (Suppl 1):12 (DOI 10.1186/cc2158)
Objectives Platelet dysfunction and surgical bleeding are the most
important causes of blood loss after cardiopulmonary bypass
(CPB). The aim of this study was to find out whether there is a cor-
relation between pre- and postbypass PFA-100 (Dade Diagnos-
tika, GmbH, Germany) in vitro bleeding time and blood loss within
the first 6 postoperative hours.
Methods After local ethics committee approval, 110 consecutive
patients scheduled for elective first time coronary artery bypass
grafting (CABG) were enrolled. Platelet function was assessed
using a PFA-100 analyzer with epinephrine-mediated platelet acti-
vation. The measurements were performed 15 min before skin inci-
sion and 15 min after protamine administration. Patients were
classified as increased bleeders (blood loss >600 ml/6 hours) and
normal bleeders (blood loss <600 ml/6 hours). PFA values greater
than 180 s were considered abnormal.
Results See Figure 1 opposite. Increased bleeding occurred in 28
patients and 82 had normal blood loss. Prebypass PFA values
showed a sensitivity of 75% and a specificity of 65% for increased
bleeding, whereas postbypass PFA values showed a sensitivity of
60% and a specificity of 41%. No patient required surgical re-
exploration.
Conclusion In this study, prebypass PFA values identified 75% of
the patients with increased bleeding risk due to pre-existing (mainly
drug-induced) platelet dysfunction. Postbypass PFA values, reflect-
ing drug-induced and CPB-related platelet dysfunction as well as a
combination of both, showed the same sensitivity and specificity
problems as reported in previous studies. A differential diagnosis
based exclusively on this point-of-care test appears to be, in pres-
ence of a mixed etiology, less reliable. However, our data suggest
that, in addition to the classic differential diagnosis management ofS7
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postoperative bleeding, the identification of increased bleeders with
normal PFA values (false negative) may facilitate the decision for
early surgical re-exploration. Also, the identification of increased
bleeders with abnormal PFA values (true positive) may help to select
patients who can benefit from administration of desmopressin or
platelets. Therefore, routine use of PFA (with epinephrine-mediated
platelet activation) may provide a useful additional information for the
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